(Q34056878)

English

Intermittent androgen blockade in prostate cancer: rationale and clinical experience

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

title

Intermittent androgen blockade in prostate cancer: rationale and clinical experience (English)

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Wolff JM

1

1 reference

stated in

Europe PubMed Central

PubMed ID

11025372

retrieved

30 July 2017

Tunn UW

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

11025372

retrieved

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

38

1 reference

stated in

Europe PubMed Central

30 July 2017

4

1 reference

stated in

Europe PubMed Central

30 July 2017

365-371

1 reference

stated in

Europe PubMed Central

PubMed ID

11025372

retrieved

30 July 2017

Identifiers

DOI

10.1159/000020310

1 reference

stated in

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

PubMed ID

11025372

retrieved

30 July 2017

(Q34056878)

Intermittent androgen blockade in prostate cancer: rationale and clinical experience

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)